Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024 at 19:09 PM EDT
CNBC's Jim Cramer on Tuesday told investors why he continues to be bullish about pharmaceutical giant Eli Lilly.
